of COVID-19 Vaccines to Patients Receiving Teriparatide
acute respiratory syndrome coronavirus 2 is an emerging virus that
has caused the recent COVID-19 pandemic.1
Recently, vaccines have been developed against SARS-CoV-2 and
additional vaccines are expected to be available in the coming
Vaccination With Teriparatide
use of a SARS-CoV-2 vaccine in patients treated with teriparatide has
not been studied by Lilly.
regarding the use of any vaccination, including SARS-CoV-2 vaccines,
in patients treated with teriparatide should be made at the
discretion of the prescribing physician using their best clinical
judgment, and must be made by the clinician after careful
consideration of risk factors of the patient as well as the risks and
benefits of vaccination. Consultation with an infectious disease
expert may be helpful in high-risk or emergency situations such as
the current COVID-19 pandemic.
Against COVID-19 Treatment Guidance in Patients With Osteoporosis
for the management of patients with osteoporosis in relation to
COVID-19 vaccination have been published by the International
the most current information please refer to Joint
Guidance on COVID-19 Vaccination and Osteoporosis Management.3
information on COVID-19 vaccines and osteoporosis is available at the
web page of the Royal Osteoporosis Society at Coronavirus
Disease Resources for COVID-19
current information on COVID-19, please refer to
Dong Y, Dai T, Wei Y, et al. A systematic review of SARS-CoV-2
vaccine candidates. Signal Transduct Target Ther.
Su Z, Wen J, McDonnell D, et al. Vaccines are not yet a silver
bullet: the imperative of continued communication about the
importance of COVID-19 safety measures. Brain Behav Immun Health.
Joint Guidance on COVID-19 Vaccination and Osteoporosis Management.
The International Osteoporosis Foundation. March 9, 2021. Accessed
March 26, 2021.
Coronavirus and osteoporosis. Royal Osteoporosis Society. December
11, 2020. Accessed May 3, 2021.
Coronavirus disease (COVID-19) outbreak. European web page of the
World Health Organization. Accessed March 26, 2021.
COVID-19. European Centre for Disease Prevention and Control.
Accessed March 26, 2021.
= coronavirus disease 2019
= Eli Lilly and Company
= severe acute respiratory syndrome coronavirus 2
WHO = World Health Organization (European regional office)
= European Centre for Disease Prevention and Control